What does this research mean for the field?

The previously published findings identifying ARAP3 as a novel oncogene in papillary thyroid carcinoma are invalid due to duplicated image panels. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aimed to identify novel oncogenes in papillary thyroid carcinoma using next-generation sequencing.

May 19, 2026Open Access

Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma Retraction

Key Points

This research aimed to identify novel oncogenes in papillary thyroid carcinoma using next-generation sequencing.
Utilized next-generation sequencing to analyze genetic alterations.
Identified ARAP3 as a potential novel oncogene in papillary thyroid carcinoma.
The findings suggested ARAP3's role as an oncogene, but are now questioned due to image duplication issues.

Abstract

duplicate image panels representative of different treatment conditions present in Figure 4.

Bookmark

View Full Paper

Bookmark

View Full Paper

Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma Retraction

Key Points

Abstract

Cite This Study